Information in product’s part of this page is provided within public professional information service. ABOUT ZENTIVAWhen and why was the Zentiva Group established?
The Zentiva Group was established in August 2003 via the merger of Léčiva a.s (Czech Republic).and Slovakofarma (Slovakia). These were the leading and most successful pharmaceutical companies in their respective markets. From this strong platform, Zentiva continued to expand into new market with the acquisition of the Romanian company Sicomed in 2005 and in 2007 Zentiva entered the Turkish market via the acquisition of Eczacibasi Generic Pharmaceuticals. As a result ot these acquistions and strong organic growth in Poland and Russia, the Zentiva Group became one of the biggest pharmaceutical companies in Central and East Europe, with the resources necessary for its future development and growth. You may obtain more detailed information in the history section.
Where is Zentiva based?
The Zentiva Group’s most important markets are in the Czech Republic, Slovakia, Turkey, Russia, Poland and Romania. However, Zentiva is expanding its activities in other countries of Central and Eastern Europe such as Ukraine, Baltic states, CIS and Bulgaria. You may find the addresses of all the commercial units and production plants in the Contact section. ZENTIVA'S PRODUCTSWhat types of products does Zentiva offer?
Zentiva’s product range includes branded pharmaceutical generics, dietary supplements and active pharmaceutical ingredients. How many products does Zentiva offer?
Zentiva markets about 270 products in some 500 pharmaceutical presentations. Of these, about 170 are sold under prescription, while 100 are available as over-the-counter (OTC) medicines and dietary supplements. On which therapeutic areas does Zentiva concentrate?
While Zentiva addresses a large number of therapeutic areas, its primary focus is on the treatment of cardiovascular disorders and diabetes, inflammatory conditions, pain, infection and diseases of the central nervous system and of the gastrointestinal and urinary tracts. BRANDED EQUIVALENTS / GENERICS What is a branded equivalent?
Generic products are equivalents of original pharmaceutical products; they may enter the market after the expiration of the patent coverage of the original products. They contain the same active substance, fulfil the same exacting criteria during development, production and safety assessment, and have the same quality, safety and efficacy as the original branded products. The generic products are either marketed as branded products, bearing their own trademark (e.g. Ibalgin®, which contains the active substance ibuprofen), or unbranded products, using simplified names of the respective active substance (e.g. diclofenac, metformin). What is the most principal importance of the generic equivalents?
They are available at reduced prices, thus increasing the availability of modern drugs. The generic equivalents are available at prices 20-80% lower than those of the original drugs. Their quality, efficacy and safety are equal to those of the original drugs. They support the process of innovation by forming a competitive environment for the original products. Should the original drug have a permanent monopoly, there would be no reason for further innovation. Generic drugs are equivalent to original drugs and their broader use results in savings, which may allow the increased use of more expensive original drugs where necessary. Why are the generic equivalents cheaper than the original drugs?
If the original drug is covered by a patent in a specified market, it will have a monopoly position. In order to recoup the high costs of a drug‘s development, the company will likely charge a high price. The lower cost of generic equivalents reflects the fact that not all development stages need to be repeated. Development of a generic product and its sale price can therefore be significantly cheaper.
How is safety and efficacy of the generic equivalents guaranteed?
Prior to marketing, every pharmaeutical product must pass a registration procedure. Registration procedure in the Czech Republic is carried out by the State Institute for Drug Control, under the guidance of the Health Ministry of the Czech Republic. In compliance with the Act No. 79/1997 Coll., as subsequently amended, safety, efficacy and quality of the product are assessed during the registration procedure. The registration of a drug is a legal confirmation of its safety, efficacy and quality. During the registration procedure identical criteria are applied to the generic equivalents and the original drugs. The registration decree is effective for five years. During this period the manufacturer is obliged to evaluate the product safety; this applies to both its own product and all other products containing the same active pharmaceutical substance. Any renewal of the registration is based on a summary report on the product safety in the past period.
For more information about branded equivalents click here.
JOBS AT ZENTIVAI would like to work at Zentiva group. How do I apply?
Visit our web site at Careers section. You can find the current list of vacancies there. If you are interested in any of the positions listed, do not hesitate to send us your CV. This is the easiest way to move into our database. However, you can send CV by post or fax.
Address: Zentiva, k.s., Human Resources Department, U Kabelovny 130, 102 37 Praha 10.
Fax: +420 272 701 900 Feel free to visit the Careers - FAQ for more information. ZENTIVA'S CORPORATE CITIZENSHIPWhat does Zentiva do to protect the environment?
Zentiva regards effective management of the environment as a very high corporate priority. We use the latest technology to ensure that environmental resources are protected and their use minimized. Furthermore, we aim to comply fully to all environmental legal regulations relating to the safeguarding of air, water and soil qualilty. In 2001, Zentiva received ISO 14001 certification, entering the new millennium as an environmentally managed firm. Is Zentiva involved in any social or cultural activity?
Zentiva is well aware of its responsibility towards the society we live in. As part of our efforts to improve the general well-being, we sponsor a number of cultural, scientific, sports and educational initiatives. You can find a list of our most significant sponsorships and events here. |